Back

Clinical multi-omics reveals the role of Tuomin Zhiti Decoction Intervention in Allergic Rhinitis from the perspective of biological network

Zhao, W.; Wang, B.; Kong, L.; Wang, Q.; Li, S.

2024-03-13 allergy and immunology
10.1101/2024.03.10.24303911
Show abstract

BackgroundIncreasing evidence showed that seasonal allergic rhinitis (SAR), as an allergy disease, could be alleviated with traditional Chinese medicine (TCM) formula, one example being Tuomin Zhiti Decoction (TZD). However, as a complex composition of TCM herbs, the mechanism of TZD in the treatment of SAR remain unclear. PurposeUncover the mechanism of TZD for treating SAR based on computational analysis and clinical multi-omics experiments. Study designIntegrate computational analysis including network target analysis and machine learning algorithms with clinical multi-omics experiments and public omics data. MethodsBy analyzing TZDs composition through a network-based method, we identified the biological effects of each compound, constructing a comprehensive biological network to elucidate TZDs molecular and pathway mechanisms against AR. Single-arm clinical trials on the gut microbiome and serum transcriptomics corroborated our computational insights. Further validation through public omics data highlighted key TZD compounds, paving the way for future research. ResultsTZD was discovered to exert a regulatory effect on various modules associated with AR, as demonstrated by the constructed biological network. Insights from gut microbiome and serum transcriptomics in clinical trials, where immune-related microbiomes represented by Prevotella, as well as pathways and biological processes including antigen processing and presentation, activation and regulating immune cell surface receptor, were markedly enriched (P value < 0.05), indicated that TZD played a pivotal role in modulating immune processes and the immune cells against AR. With the verification of multi-omics, it was determined that TZD potentially influences immune responses and downstream immune cells like CD4+ T cells, through both direct mechanisms involving antigen and indirect mechanisms mediated by gut microbiomes in the treatment of AR. ConclusionThrough combination of computational prediction and analysis together with clinical multi-omics, a network target based framework provided a new insight for uncovering the mechanism of TZD for treating AR.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Allergy
based on 13 papers
Top 0.1%
16.3%
2
Frontiers in Immunology
based on 140 papers
Top 0.7%
8.0%
3
eLife
based on 262 papers
Top 2%
6.8%
4
PLOS ONE
based on 1737 papers
Top 67%
5.3%
5
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 0.2%
4.8%
6
Medicine
based on 29 papers
Top 2%
3.0%
7
Journal of Translational Medicine
based on 21 papers
Top 0.1%
3.0%
8
Genomics, Proteomics & Bioinformatics
based on 10 papers
Top 0.4%
3.0%
50% of probability mass above
9
Scientific Reports
based on 701 papers
Top 51%
3.0%
10
Nature Communications
based on 483 papers
Top 23%
2.7%
11
Cells
based on 14 papers
Top 0.3%
2.6%
12
Cell Genomics
based on 34 papers
Top 1.0%
2.6%
13
Clinical Immunology
based on 12 papers
Top 0.4%
2.6%
14
Journal of Experimental Medicine
based on 10 papers
Top 0.4%
2.4%
15
The Journal of Immunology
based on 19 papers
Top 0.9%
2.0%
16
Communications Biology
based on 36 papers
Top 1%
1.7%
17
iScience
based on 74 papers
Top 3%
1.7%
18
Environmental Research
based on 36 papers
Top 2%
1.4%
19
Biology
based on 11 papers
Top 0.7%
1.3%
20
Cell Reports Medicine
based on 49 papers
Top 5%
0.8%
21
Nature Immunology
based on 14 papers
Top 1%
0.8%
22
Gut Microbes
based on 15 papers
Top 1%
0.8%
23
Signal Transduction and Targeted Therapy
based on 10 papers
Top 0.7%
0.8%
24
Frontiers in Medicine
based on 99 papers
Top 20%
0.7%
25
eBioMedicine
based on 82 papers
Top 8%
0.7%
26
Molecular Psychiatry
based on 84 papers
Top 6%
0.7%
27
Journal of Medical Virology
based on 95 papers
Top 10%
0.7%
28
Gut
based on 17 papers
Top 3%
0.7%
29
Chemical Senses
based on 11 papers
Top 0.5%
0.7%
30
British Journal of Cancer
based on 22 papers
Top 4%
0.7%